Integration of traditional and modern medicine
Start with the big picture
The integration process begins with documenting traditional use and evaluating therapies through phytochemical profiling, pre-clinical studies, clinical trials, and ongoing safety monitoring. Reverse pharmacology can use observed therapeutic effects to guide research. Quality assurance draws on marker compounds, chromatographic fingerprints, DNA barcoding, and practices such as GACP and GMP to address variation in plant identity and production. Regulatory approaches differ across regions, while tools such as the TKDL, the Nagoya Protocol, and community consent agreements support protection and benefit-sharing. Integration also calls for sustainable sourcing, careful assessment of herb–drug interactions, and pharmacovigilance for herbal adverse reactions. Clinical research methods and omics can help investigate complex treatments and mechanisms, supported by multidisciplinary collaboration.
What you'll learn
- Outline the stages involved in translating traditional therapies into clinical research and practice.
- Describe how analytical methods and good practices support botanical identity and quality.
- Identify approaches to regulation, intellectual-property protection, benefit-sharing, and conservation.
- Explain why herb–drug interactions and herbal adverse reactions require monitoring.
- Summarize how clinical research, omics, and multidisciplinary teams contribute to integration.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
